Status:
COMPLETED
Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage
Lead Sponsor:
Galderma R&D
Conditions:
Photoaging
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
The primary purpose of this study is to compare the efficacy of adapalene (Differin®) gel 0.3% and tretinoin 0.05% emollient cream for the treatment of signs of photodamage, with tolerability assessme...
Detailed Description
Same as above.
Eligibility Criteria
Inclusion
- Male or Female aged 40 years of age and older with Fitzpatrick skin types I through III
- Clinically moderate to severe photodamage
Exclusion
- Subjects with history of laser resurfacing, dermabrasion, medium or deep chemical peel of the face
- Subjects with diagnosis of skin cancer within 3 months of study entry
- Subjects who have had superficial chemical peels, exfoliation or microdermabrasion of the face within 3 months of study entry
- Subjects who have had botulinum toxin for facial rejuvenation within 6 months of study entry and are unwilling to refrain from botulinum toxin treatments during the study
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00647556
Start Date
April 1 2008
End Date
January 1 2010
Last Update
August 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Department of Dermatology
Ann Arbor, Michigan, United States, 48109